{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:10:14Z","timestamp":1789067414914,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04200-5","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:03:50Z","timestamp":1748585030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of thrombomodulin with the severity of chronic kidney disease: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ming","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinggang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"4","key":"4200_CR1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"PE Stevens","year":"2024","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4):S117\u2013314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018.","journal-title":"Kidney Int"},{"issue":"12","key":"4200_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. CJASN. 2017;12(12):2032\u201345. https:\/\/doi.org\/10.2215\/CJN.11491116.","journal-title":"CJASN"},{"issue":"10225","key":"4200_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3.","journal-title":"Lancet"},{"key":"4200_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fmed.2017.00168","volume":"4","author":"M Araujo","year":"2017","unstructured":"Araujo M, Doi SQ, Editorial. Biomarkers in CKD. Front Med. 2017;4:168. https:\/\/doi.org\/10.3389\/fmed.2017.00168.","journal-title":"Front Med"},{"issue":"6","key":"4200_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3390\/toxins12060361","volume":"12","author":"M Diaz-Ricart","year":"2020","unstructured":"Diaz-Ricart M, Torramade-Moix S, Pascual G, et al. Endothelial damage, inflammation and immunity in chronic kidney disease. Toxins. 2020;12(6):361. https:\/\/doi.org\/10.3390\/toxins12060361.","journal-title":"Toxins"},{"issue":"5","key":"4200_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3390\/life11050419","volume":"11","author":"F Tinti","year":"2021","unstructured":"Tinti F, Lai S, Noce A, et al. Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment. Life. 2021;11(5):419. https:\/\/doi.org\/10.3390\/life11050419.","journal-title":"Life"},{"issue":"3","key":"4200_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1681\/ASN.2016040453","volume":"28","author":"KL Nowak","year":"2017","unstructured":"Nowak KL, Chonchol M, Ikizler TA, et al. IL-1 Inhibition and vascular function in CKD. J Am Soc Nephrol. 2017;28(3):971. https:\/\/doi.org\/10.1681\/ASN.2016040453.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"4200_CR8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.2215\/CJN.08660813","volume":"9","author":"MI Yilmaz","year":"2014","unstructured":"Yilmaz MI, Solak Y, Saglam M, et al. The relationship between IL-10 levels and cardiovascular events in patients with CKD. Clin J Am Soc Nephrol. 2014;9(7):1207. https:\/\/doi.org\/10.2215\/CJN.08660813.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4200_CR9","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur RL, Feldman HI, Gupta J, et al. Inflammation and progression of CKD: the CRIC study. Clin J Am Soc Nephrol. 2016;11(9):1546. https:\/\/doi.org\/10.2215\/CJN.13121215.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"4200_CR10","doi-asserted-by":"publisher","first-page":"e014294","DOI":"10.1136\/bmjopen-2016-014294","volume":"7","author":"MJ Huang","year":"2017","unstructured":"Huang MJ, Wei Rbao, Wang Y, et al. Blood coagulation system in patients with chronic kidney disease: a prospective observational study. BMJ Open. 2017;7(5):e014294. https:\/\/doi.org\/10.1136\/bmjopen-2016-014294.","journal-title":"BMJ Open"},{"issue":"2","key":"4200_CR11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood.V75.2.329.329","volume":"75","author":"WA Dittman","year":"1990","unstructured":"Dittman WA. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 1990;75(2):329\u201336. https:\/\/doi.org\/10.1182\/blood.V75.2.329.329.","journal-title":"Blood"},{"issue":"1","key":"4200_CR12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","volume":"34","author":"EM Conway","year":"2012","unstructured":"Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol. 2012;34(1):107\u201325. https:\/\/doi.org\/10.1007\/s00281-011-0282-8.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"4200_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/138945012799424606","volume":"13","author":"J Morser","year":"2012","unstructured":"Morser J. Thrombomodulin links coagulation to inflammation and immunity. CDT. 2012;13(3):421\u201331. https:\/\/doi.org\/10.2174\/138945012799424606.","journal-title":"CDT"},{"issue":"1","key":"4200_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2332\/allergolint.13-OA-0595","volume":"63","author":"M Toda","year":"2014","unstructured":"Toda M, D\u2019Alessandro-Gabazza CN, Takagi T, et al. Thrombomodulin modulates dendritic cells via both antagonism of high mobility group protein B1 and an independent mechanism. Allergology Int. 2014;63(1):57\u201366. https:\/\/doi.org\/10.2332\/allergolint.13-OA-0595.","journal-title":"Allergology Int"},{"issue":"4","key":"4200_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00041433-200308000-00006","volume":"14","author":"KK Wu","year":"2003","unstructured":"Wu KK. Soluble thrombomodulin and coronary heart disease. Curr Opin Lipidol. 2003;14(4):373\u20135. https:\/\/doi.org\/10.1097\/00041433-200308000-00006.","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"4200_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13054-017-1815-x","volume":"21","author":"S Katayama","year":"2017","unstructured":"Katayama S, Nunomiya S, Koyama K, et al. Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin. Crit Care. 2017;21(1):229. https:\/\/doi.org\/10.1186\/s13054-017-1815-x.","journal-title":"Crit Care"},{"key":"4200_CR17","doi-asserted-by":"publisher","first-page":"107602962097104","DOI":"10.1177\/1076029620971041","volume":"26","author":"K Zhou","year":"2020","unstructured":"Zhou K, Zhang J, Zheng ZR, et al. Diagnostic and prognostic value of TAT, PIC, TM, and t-PAIC in malignant tumor patients with venous thrombosis. Clin Appl Thromb Hemost. 2020;26:1076029620971041. https:\/\/doi.org\/10.1177\/1076029620971041.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"4200_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","volume":"132","author":"H Loghmani","year":"2018","unstructured":"Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148\u201358. https:\/\/doi.org\/10.1182\/blood-2017-12-768994.","journal-title":"Blood"},{"key":"4200_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1076029620944471","volume":"26","author":"L Li","year":"2020","unstructured":"Li L, Gao L, Wu X, et al. Changes in biomarkers of coagulation, fibrinolytic, and endothelial functions for evaluating the predisposition to venous thromboembolism in patients with hereditary thrombophilia. Clin Appl Thromb Hemost. 2020;26:1\u20137. https:\/\/doi.org\/10.1177\/1076029620944471.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"4200_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"6","key":"4200_CR21","doi-asserted-by":"publisher","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","volume":"3","author":"C Schulthei\u00df","year":"2022","unstructured":"Schulthei\u00df C, Willscher E, Paschold L, et al. The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3(6):100663. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100663.","journal-title":"Cell Rep Med"},{"key":"4200_CR22","doi-asserted-by":"publisher","unstructured":"Sw B, Ea C. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn. 2020;20(10). https:\/\/doi.org\/10.1080\/14737159.2020.1768849.","DOI":"10.1080\/14737159.2020.1768849"},{"issue":"15","key":"4200_CR23","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2011.468","volume":"305","author":"CA Peralta","year":"2011","unstructured":"Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, Cystatin C, and urine Albumin-to-Creatinine ratio and association with progression to End-Stage renal disease and mortality. JAMA. 2011;305(15):1545\u201352. https:\/\/doi.org\/10.1001\/jama.2011.468.","journal-title":"JAMA"},{"issue":"4","key":"4200_CR24","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1080\/21645515.2018.1555569","volume":"15","author":"MH Foster","year":"2019","unstructured":"Foster MH, Ord JR. Emerging immunotherapies for autoimmune kidney disease. Hum Vaccines Immunotherapeutics. 2019;15(4):876\u201390. https:\/\/doi.org\/10.1080\/21645515.2018.1555569.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"4200_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev.pathol.1.110304.100119","volume":"1","author":"C Kwoh","year":"2006","unstructured":"Kwoh C, Shannon MB, Miner JH, Shaw A, PATHOGENESIS OF NONIMMUNE GLOMERULOPATHIES. Annu Rev Pathol. 2006;1:349\u201374. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100119.","journal-title":"Annu Rev Pathol"},{"key":"4200_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1056\/NEJMra022161","volume":"350","author":"PD Wilson","year":"2004","unstructured":"Wilson PD. Polycystic kidney disease. N Engl J Med. 2004;350:151\u201364. https:\/\/doi.org\/10.1056\/NEJMra022161.","journal-title":"N Engl J Med"},{"issue":"1","key":"4200_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/gft209","volume":"29","author":"J Lutz","year":"2014","unstructured":"Lutz J, Menke J, Sollinger D, Schinzel H, Th\u00fcrmel K. Haemostasis in chronic kidney disease. Nephrol Dialysis Transplantation. 2014;29(1):29\u201340. https:\/\/doi.org\/10.1093\/ndt\/gft209.","journal-title":"Nephrol Dialysis Transplantation"},{"key":"4200_CR28","doi-asserted-by":"publisher","first-page":"118295","DOI":"10.1016\/j.lfs","volume":"260","author":"F Fonseca","year":"2020","unstructured":"Fonseca F, Ballerini AP, Izar MC, et al. Advanced chronic kidney disease is associated with higher serum concentration of monocyte microparticles. Life Sci. 2020;260:118295. https:\/\/doi.org\/10.1016\/j.lfs. 2020.118295.","journal-title":"Life Sci"},{"issue":"5","key":"4200_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0049-3848(93)90246-K","volume":"72","author":"O Hergesell","year":"1993","unstructured":"Hergesell O, Andrassy K, Geberth S, Nawroth P, Gabath S. Plasma thrombomodulin levels are dependent on renal function. Thromb Res. 1993;72(5):455\u20138. https:\/\/doi.org\/10.1016\/0049-3848(93)90246-K.","journal-title":"Thromb Res"},{"issue":"3","key":"4200_CR30","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/ndt\/17.3.526","volume":"17","author":"B Naumnik","year":"2002","unstructured":"Naumnik B, Borawski J, Pawlak K, My\u015bliwiec M. Renal function, proteinuria and ACE-inhibitor therapy as determinants of plasma levels of endothelial markers. Nephrol Dialysis Transplantation. 2002;17(3):526\u20138. https:\/\/doi.org\/10.1093\/ndt\/17.3.526.","journal-title":"Nephrol Dialysis Transplantation"},{"issue":"1","key":"4200_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/107602960200800113","volume":"8","author":"J Borawski","year":"2002","unstructured":"Borawski J, Naumnik B, Mys\u2019liwiec M. Increased soluble thrombomodulin does not always indicate endothelial injury. Clin Appl Thromb Hemost. 2002;8(1):87\u20139. https:\/\/doi.org\/10.1177\/107602960200800113.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"4200_CR32","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1681\/ASN.2011010084","volume":"22","author":"A Karihaloo","year":"2011","unstructured":"Karihaloo A, Koraishy F, Huen SC, et al. Macrophages promote cyst growth in polycystic kidney disease. J Am Soc Nephrol. 2011;22(10):1809. https:\/\/doi.org\/10.1681\/ASN.2011010084.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4200_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/nep.12045","volume":"18","author":"MHT Ta","year":"2013","unstructured":"Ta MHT, Harris DCH, Rangan GK. Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrol (Carlton). 2013;18(5):317\u201330. https:\/\/doi.org\/10.1111\/nep.12045.","journal-title":"Nephrol (Carlton)"},{"issue":"4","key":"4200_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/ki.1991.87","volume":"39","author":"KD Gardner","year":"1991","unstructured":"Gardner KD, Burnside JS, Elzinga LW, Locksley RM. Cytokines in fluids from polycystic kidneys. Kidney Int. 1991;39(4):718\u201324. https:\/\/doi.org\/10.1038\/ki.1991.87.","journal-title":"Kidney Int"},{"issue":"11","key":"4200_CR35","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1681\/ASN.0000000000000199","volume":"34","author":"Z Qiu","year":"2023","unstructured":"Qiu Z, Pang X, Xiang Q, Cui Y. The crosstalk between nephropathy and coagulation disorder: pathogenesis, treatment, and dilemmas. JASN. 2023;34(11):1793\u2013811. https:\/\/doi.org\/10.1681\/ASN.0000000000000199.","journal-title":"JASN"},{"issue":"7","key":"4200_CR36","doi-asserted-by":"publisher","first-page":"e21725","DOI":"10.1096\/fj.202002652RR","volume":"35","author":"CC Gifford","year":"2021","unstructured":"Gifford CC, Lian F, Tang J. al.PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of Klotho, p53, and TGF\u2010\u03b21\u2010receptor signaling. FASEB J. 2021;35(7):e21725. https:\/\/doi.org\/10.1096\/fj.202002652RR.","journal-title":"FASEB J"},{"issue":"4","key":"4200_CR37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2013101137","volume":"26","author":"S Xavier","year":"2015","unstructured":"Xavier S, Vasko R, Matsumoto K, et al. Curtailing endothelial TGF-\u03b2 signaling is sufficient to reduce endothelial-Mesenchymal transition and fibrosis in CKD. J Am Soc Nephrol. 2015;26(4):817. https:\/\/doi.org\/10.1681\/ASN.2013101137.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4200_CR38","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.kint.2020.05.041","volume":"98","author":"A Takeshita","year":"2020","unstructured":"Takeshita A, Yasuma T, Nishihama K, et al. Thrombomodulin ameliorates transforming growth factor-\u03b21\u2013mediated chronic kidney disease via the G-protein coupled receptor 15\/akt signal pathway. Kidney Int. 2020;98(5):1179\u201392. https:\/\/doi.org\/10.1016\/j.kint.2020.05.041.","journal-title":"Kidney Int"},{"issue":"4","key":"4200_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/1354750X.2014.904000","volume":"19","author":"YS Bao","year":"2014","unstructured":"Bao YS, Jia XB, Wang D, Liu RC, Zou CB, Na SP. Characterization of soluble thrombomodulin levels in patients with stage 3\u20135 chronic kidney disease. Biomarkers. 2014;19(4):275\u201380. https:\/\/doi.org\/10.3109\/1354750X.2014.904000.","journal-title":"Biomarkers"},{"issue":"4","key":"4200_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","volume":"67","author":"P Stenvinkel","year":"2005","unstructured":"Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF-\u03b1: central factors in the altered cytokine network of uremia\u2014The good, the bad, and the ugly. Kidney Int. 2005;67(4):1216\u201333. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00200.x.","journal-title":"Kidney Int"},{"issue":"2","key":"4200_CR41","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/S0002-9149(03)00536-8","volume":"92","author":"R Sharma","year":"2003","unstructured":"Sharma R, Bolger AP, Li W, et al. Elevated Circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol. 2003;92(2):188\u201393. https:\/\/doi.org\/10.1016\/S0002-9149(03)00536-8.","journal-title":"Am J Cardiol"},{"issue":"12","key":"4200_CR42","doi-asserted-by":"publisher","first-page":"e22622","DOI":"10.1096\/fj.202200923R","volume":"36","author":"R Nishad","year":"2022","unstructured":"Nishad R, Mukhi D, Kethavath S, et al. Podocyte derived TNF-\u03b1 mediates monocyte differentiation and contributes to glomerular injury. FASEB J. 2022;36(12):e22622. https:\/\/doi.org\/10.1096\/fj.202200923R.","journal-title":"FASEB J"},{"key":"4200_CR43","doi-asserted-by":"publisher","unstructured":"Acosta-Ampudia Y, Monsalve DM, Rojas M et al. Persistent autoimmune activation and Proinflammatory state in Post-COVID syndrome. MedRxiv 2021.11.17. 21266457. https:\/\/doi.org\/10.1101\/2021. 11.17.21266457.","DOI":"10.1101\/2021"},{"issue":"10","key":"4200_CR44","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/jth.15490","volume":"19","author":"H Fogarty","year":"2021","unstructured":"Fogarty H, Townsend L, Morrin H, et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. 2021;19(10):2546\u201353. https:\/\/doi.org\/10.1111\/jth.15490.","journal-title":"J Thromb Haemost"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04200-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04200-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:03:50Z","timestamp":1748585030000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04200-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4200"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04200-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the General Hospital of the People\u2019s Liberation Army (registration number: S2022-747-01). Each participant signed an informed consent for the enrolment and the study was conducted following the guidelines of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}